FDA considers over-the-counter birth control pill approval.

The FDA is considering approving over-the-counter birth control pills by the summer, but expressed concerns over errors in submitted data on the drug's safety. The agency worries that access to the drug without a prescription may lead to increased errors in usage. Labels for norgestrel, the contraceptive drug requested to be made available over-the-counter, detail the importance of property timed usage, risk of recurring breast cancer, and a need to consult a doctor about usage if struggling with vaginal bleeding. The FDA criticized the submitted data over an underestimate of participants with limited literacy and noted that the data is more than two decades old.